Growth Hormone Clinical Trial
Official title:
A Randomized Control Trial to Investigate the Effect of Growth Hormone on the Euploid Rate of Blastocyst in Patients With Advanced Maternal Age
This randomized trial aims to compare the euploid rate of blastocysts in AMA patients undergoing PGT-A (preimplantation genetic testing for aneuploidy) with or without growth hormone supplement. Infertile patients ≥38 years old will be recruited for study after informed consent if they fulfill the inclusion criteria and do not have the exclusion criteria. Eligible women will be randomised into one of the two groups: Treatment group: Women will receive growth hormone (GH) supplement before and during antagonist protocol for ovarian stimulation. Control group: Women will receive antagonist protocol for ovarian stimulation. The primary outcome is the euploidy rate of blastocysts.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04079010 -
The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone
|
N/A | |
Completed |
NCT01540773 -
Single Low-Dose of Supplement Amino Acid
|
N/A | |
Completed |
NCT00562796 -
Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity
|
N/A | |
Completed |
NCT05574894 -
Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study
|
Phase 3 | |
Completed |
NCT01158612 -
The Effect of Local Injectet GH on the Collagen Synthesis in the Ligamentum Patella
|
N/A | |
Completed |
NCT00966134 -
Ghrelin, Growth Hormone and Growth Factors at High Altitude
|
N/A | |
Active, not recruiting |
NCT06433375 -
Evaluation of the Efficacy of Growth Hormone on Healing of Periapical Pathosis
|
N/A |